DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Negative impactCompany

Cipla Share Price Live Updates: Cipla's Price Movement Signals Weakness

Economic Times 3 hrs ago·17 Aug 2026, 3:00 am

Cipla's stock price is currently showing signs of weakness, reflecting a downward trend in its market value. This movement suggests that investor sentiment has turned negative, with the stock facing selling pressure in recent sessions.

For investors, this development is significant as it indicates that the stock may be struggling to maintain its previous levels. A weakening trend can be a warning sign, prompting investors to reassess their holdings and the company's future performance.

Going forward, market participants should closely monitor the stock's reaction to key support levels. Any further decline could signal deeper issues, while a recovery might suggest a potential reversal in the short term.